A review of current and emerging therapeutic options for hemophagocytic lymphohistiocytosis

J Summerlin, DA Wells… - Annals of …, 2023 - journals.sagepub.com
Objective: To provide an overview of clinical sequelae and emerging treatment options for
hemophagocytic lymphohistiocytosis (HLH). Data Sources: A literature search was …

[HTML][HTML] Cytokines from bench to bedside: A retrospective study identifies a definite panel of biomarkers to early assess the risk of negative outcome in COVID-19 …

M Fabris, F Del Ben, E Sozio, AP Beltrami… - International Journal of …, 2022 - mdpi.com
The main aim of this study was to identify the most relevant cytokines which, when assessed
in the earliest stages from hospital admission, may help to select COVID-19 patients with …

[HTML][HTML] Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states

LF Schimke, AHC Marques, GC Baiocchi… - Cells, 2022 - mdpi.com
Severe COVID-19 patients present a clinical and laboratory overlap with other
hyperinflammatory conditions such as hemophagocytic lymphohistiocytosis (HLH) …

Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection

P Brito Zerón, N Acar Denizli… - Clinical and …, 2021 - upcommons.upc.edu
OBJECTIVES: To analyse the frequency and characteristics of post-COVID-19 syndrome in
patients with primary Sjögren's syndrome (pSS) affected by acute SARS-CoV-2 infection …

[HTML][HTML] Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov‐19 vaccination

S Ai, A Awford, F Roncolato - Journal of Medical Virology, 2022 - ncbi.nlm.nih.gov
To the Editor, The emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) and the resulting pandemic has led to the rapid production of several vaccines with …

[HTML][HTML] Hemophagocytic lymphohistiocytosis, a new cause of death during 'post-acute COVID-19 syndrome?'A case report

E Naous, BM Nassani, C Yaghi, F Nasr… - Journal of …, 2021 - Springer
Abstract 'Post-acute coronavirus disease 2019 (COVID-19) syndrome'is a new term that was
coined to describe a constellation of persistent symptoms and new complications following …

[HTML][HTML] Inflammatory factors and risk of meningiomas: a bidirectional mendelian-randomization study

Z Zhang, S Wang, F Ren, L Yang, H Xie… - Frontiers in …, 2023 - frontiersin.org
Background Meningiomas are one of the most common intracranial tumors, and the current
understanding of meningioma pathology is still incomplete. Inflammatory factors play an …

[HTML][HTML] Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients

M Meng, L Chen, S Zhang, X Dong, W Li, R Li… - BMC Infectious …, 2021 - Springer
Background Secondary hemophagocytic lymphohistiocytosis (sHLH) is a life-threatening
hyperinflammatory event and a fatal complication of viral infections. Whether sHLH may also …

[PDF][PDF] Practical diagnostic tips for the Sjögren Clinic: pearls, myths and mistakes

P Brito-Zerón, S Retamozo… - Clin Exp …, 2022 - clinexprheumatol.org
More than 90 years have passed since Hendrik Sjögren began to consider that behind the
dryness that several of his patients presented, there could be a systemic disease potentially …

[HTML][HTML] Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2

GA Mostafa, HM Ibrahim, A Al Sayed Shehab… - European Journal of …, 2022 - Springer
Similar to hemophagocytic lymphohistiocytosis (HLH), some patients with SARS-CoV-2
have cytokine storm. Serum soluble interleukin-2 receptor (sCD25) and soluble CD163 …